OptimizeRx Corporation

OptimizeRx Corporation

OPRXยทNASDAQ

$5.38

+8.2%
HealthcareMedical - Healthcare Information Services

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

At a Glance

Live Snapshot
Market Cap$100.96M
EPS0.2800
P/E Ratio19.21
Earnings Date08/06/2026
3Y+75.0%
5Y+153.0%
10Y+1312.0%
3Y-145.0%
5Y-333.0%
10Y-433.0%
3Y+76.0%
5Y-397.0%
10Y-4116.0%
OptimizeRx Corporation

OptimizeRx Corporation Profit Bridge

OPRX ยท NASDAQ
Revenue109.43M
Cost of Goods Sold (40.16M)
Gross Profit69.27M
Operating Expenses (57.21M)
Operating Income12.06M
Interest Expense (5.29M)
Other Income/Expense-5.11M
Pretax Income6.95M
Income Tax (1.82M)
Net Income5.13M
Net Income
5.13M

Profitability Analysis

Gross Margin

63.3%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

11.0%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

4.7%

Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.

Effective Tax Rate

26.2%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.

OptimizeRx Corporation Income Statement

OPRX โ€ข NASDAQ

OptimizeRx Corporation Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007
REVENUE
109.4M
92.1M
71.5M
62.5M
61.3M
43.3M
24.6M
21.2M
12.1M
7.8M
7.2M
6.5M
5M
2M
1.1M
71.1K
26.7K
83.7K
100.3K
GROSS PROFIT
(40.2M)
(32.7M)
(28.6M)
(23.5M)
(25.7M)
(19.2M)
(9.2M)
(9M)
(6.2M)
(3.4M)
(3.6M)
(3.2M)
(1.8M)
(115.4K)
(0.0)
(0.0)
(2.6M)
(0.0)
(0.0)
69.3M
59.4M
42.9M
39M
35.6M
24.1M
15.4M
12.2M
6M
4.3M
3.6M
3.3M
3.2M
1.9M
1.1M
71.1K
-2.6M
83.7K
100.3K
OPERATING INCOME
(57.2M)
(73.1M)
(69.3M)
(51.3M)
(35.3M)
(26.2M)
(19.1M)
(12M)
(8.1M)
(5.9M)
(4.2M)
(3.9M)
(3M)
(2.4M)
(2.6M)
(1.9M)
(2.7M)
(1.6M)
(456.3K)
(50.2M)
(61.3M)
(58M)
(49.2M)
(33.2M)
(19.9M)
(14.6M)
(10.3M)
(6.7M)
(5.2M)
(3.3M)
(3.5M)
(2.8M)
(2.2M)
(2.6M)
(1.7M)
(2.4M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(2.7M)
(675.7K)
(1M)
(398.4K)
(290.4K)
(189.6K)
(130.3K)
(126.9K)
(0.0)
(78.4K)
(0.0)
(0.0)
(0.0)
12.1M
-13.7M
-26.4M
-12.3M
361.1K
-2.1M
-3.7M
180.1K
-2.1M
-1.6M
-597.4K
-1M
215.6K
-364.3K
-1.5M
-1.8M
-2.6M
-1.5M
-355.9K
PRE-TAX INCOME
(5.3M)
(6.2M)
(1.5M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(100.0)
(958.6K)
(106.6K)
(1K)
(611.0)
(5.5K)
-4.9M
-5.8M
738K
852.3K
17K
68.6K
288K
46.2K
25.9K
42.3K
2.3K
935.0
246.0
369.0
-957.4K
-103.7K
29.2K
4.5K
-5.5K
(7M)
(11.8M)
(11.3M)
(2M)
(2.1M)
(6.3M)
(1.9M)
(449K)
(324.6K)
(235.3K)
(584K)
(264.3K)
(194K)
(187.1K)
(0.0)
(119.1K)
(277.9K)
(1.6M)
(456.3K)
-5.1M
-5.7M
1.2M
852.3K
17K
-71.8K
-347K
46.2K
25.9K
42.3K
2.3K
935.0
246.0
369.0
-666.8K
-162.8K
738.4K
-2.7M
-5.5K
7M
-19.4M
-25.2M
-11.4M
378.1K
-2.2M
-4M
226.3K
-2.1M
-1.5M
-595.1K
-1M
215.8K
-364K
-2.1M
-2M
-4.6M
-4.2M
-361.5K
NET INCOME
(1.8M)
(725K)
-7.6M
(0.0)
(0.0)
(0.0)
-898K
(0.0)
(0.0)
(0.0)
(2.3K)
(0.0)
(426.0)
(469.0)
(0.0)
(165.7K)
(1K)
(611.0)
(0.0)
5.1M
-20.1M
-17.6M
-11.4M
378.1K
-2.2M
-3.1M
226.3K
-2.1M
-1.5M
-595.1K
-1M
215.8K
-364K
-2.1M
-2M
-4.6M
-4.2M
-361.5K

SEC Filings

OPRX - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 13, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 12, 2026
May 12, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 30, 2026
June 09, 2026
2026
8-K

8-K 2026

N/A

April 09, 2026
April 03, 2026
2026
8-K

8-K 2026

N/A

March 30, 2026
March 24, 2026
2026
10-K

10-K 2025 FY

FY

March 12, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 05, 2026
March 05, 2026
2026
10-Q

10-Q 2025 Q3

Q3

November 07, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 06, 2025
November 06, 2025
2025
8-K

8-K 2025

N/A

August 19, 2025
August 15, 2025
2025
Showing 1 to 10 of 430 filings